Sunshine Biopharma Inc Warrant
SBFMW
4 hedge funds and large institutions have $49K invested in Sunshine Biopharma Inc Warrant in 2022 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 4 closing their positions.
0.77% more ownership
Funds ownership: 0.25% → 1.01% (+0.77%)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
33% less funds holding
Funds holding: 6 → 4 (-2)
50% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 4
96% less capital invested
Capital invested by funds: $1.26M → $49K (-$1.21M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$82.8K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$17.6K |
| 3 |
Bank of America
Charlotte,
North Carolina
|
+$177 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
-$876K |
| 2 |
EAM
Empery Asset Management
New York
|
-$389K |
| 3 |
CH
CVI Holdings
Wilmington,
Delaware
|
-$74K |
| 4 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
-$59K |
| 5 |
CS
Clear Street
New York
|
-$14K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $38K | +$82.8K | +46,857 | New |
|
|
2
UBS Group
Zurich,
Switzerland
| $8K | +$17.6K | +9,948 | +1,625% |
|
|
EAM
3
Empery Asset Management
New York
| $3K | -$389K | -220,214 | -94% |
|
|
AC
4
Armistice Capital
New York
| – | -$876K | -884,600 | Closed |
|
|
CH
5
CVI Holdings
Wilmington,
Delaware
| – | -$74K | -74,632 | Closed |
|
|
6
Hudson Bay Capital Management
Stamford,
Connecticut
| – | -$59K | -60,000 | Closed |
|
|
CS
7
Clear Street
New York
| – | -$14K | -14,126 | Closed |
|
|
8
Bank of America
Charlotte,
North Carolina
| – | +$177 | +100 | New |
|
SBFMW Hedge Fund Activity: Q2 2022 in Review
4 of the 5,937 institutional investors tracked by Wall St. Rank reported a position in Sunshine Biopharma Inc Warrant (SBFMW) for Q2 2022, worth a combined $49K — down 96% from $1.26M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of SBFMW and 2 opened new positions — a net loss of 2 holders — while 1 trimmed existing stakes and 1 added.
The largest buyer was Susquehanna International Group, opening a new position worth an estimated $82.8K. The largest seller was Armistice Capital, exiting entirely with an estimated $876K sold.
- 4 institutional investors held Sunshine Biopharma Inc Warrant (SBFMW) as of Q2 2022, down from 6 in Q1 2022.
- Funds reported $49K of Sunshine Biopharma Inc Warrant stock for Q2 2022, down 96% quarter-over-quarter.
- 2 funds opened new Sunshine Biopharma Inc Warrant positions in Q2 2022 and 4 closed out, a net change of -2 holders.
- The largest Sunshine Biopharma Inc Warrant buyer in Q2 2022 was Susquehanna International Group, an estimated $82.8K added.
- The largest Sunshine Biopharma Inc Warrant seller in Q2 2022 was Armistice Capital, an estimated $876K sold.
Based on aggregated 13F filings for Q2 2022.